{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:28:26Z","timestamp":1767706106583},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.hoc.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T18:46:16Z","timestamp":1301337976000},"page":"393-413","source":"Crossref","is-referenced-by-count":14,"title":["Transfusion Medicine and the Pregnant Patient"],"prefix":"10.1016","volume":"25","author":[{"given":"Alfred Ian","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2011.02.002_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1537-2995.1961.tb00005.x","article-title":"On agglutination of normal human blood","volume":"1","author":"Landsteiner","year":"1961","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1537-2995.2009.02456.x","article-title":"Blood groups: the past 50 years","volume":"50","author":"Daniels","year":"2010","journal-title":"Transfusion"},{"issue":"23","key":"10.1016\/j.hoc.2011.02.002_bib3","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2010-01-261859","article-title":"The relationship between blood groups and disease","volume":"115","author":"Anstee","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/CRIAI:26:3:161","article-title":"Immunology of pregnancy. Implications for the mother","volume":"26","author":"Poole","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/0891693031000067304","article-title":"Microchimerism in human health and disease","volume":"36","author":"Nelson","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.hoc.2011.02.002_bib6","first-page":"378","article-title":"Icterus gravis (erythroblastosis) neonatorum","volume":"25","author":"Darrow","year":"1938","journal-title":"Arch Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.002_bib7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jama.251.10.1316","article-title":"Landmark article July 8, 1939. An unusual case of intra-group agglutination. By Philip Levine and Rufus E Stetson","volume":"251","author":"Levine","year":"1984","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.seminhematol.2006.09.010","article-title":"The structure and function of the Rh antigen complex","volume":"44","author":"Westhoff","year":"2007","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1537-2995.2009.02493.x","article-title":"Advances in red blood cell immunology 1960 to 2009","volume":"50","author":"Garratty","year":"2010","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.002_bib10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1537-2995.2005.00586.x","article-title":"Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention","volume":"45","author":"Denomme","year":"2005","journal-title":"Transfusion"},{"issue":"5519","key":"10.1016\/j.hoc.2011.02.002_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bmj.2.5519.907","article-title":"Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore","volume":"2","year":"1966","journal-title":"Br Med J"},{"issue":"5238","key":"10.1016\/j.hoc.2011.02.002_bib12","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/bmj.1.5238.1486","article-title":"Experimental studies on the prevention of Rh haemolytic disease","volume":"1","author":"Finn","year":"1961","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9378(84)80070-8","article-title":"Detection of fetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter","volume":"148","author":"Medearis","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1537-2995.1971.tb04424.x","article-title":"Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus","volume":"11","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.002_bib15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.002_bib16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1046\/j.1537-2995.2002.00239.x","article-title":"IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease","volume":"42","author":"Lambin","year":"2002","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1983.23283172867.x","article-title":"Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother","volume":"23","author":"Lacey","year":"1983","journal-title":"Transfusion"},{"issue":"5 Pt 2","key":"10.1016\/j.hoc.2011.02.002_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0029-7844(03)00709-9","article-title":"Fatal hydrops fetalis caused by anti-D in a mother with partial D","volume":"102","author":"Cannon","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.hoc.2011.02.002_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1046\/j.1537-2995.2001.41111445.x","article-title":"Practice guidelines for prenatal and perinatal immunohematology, revisited","volume":"41","author":"Judd","year":"2001","journal-title":"Transfusion"},{"issue":"24","key":"10.1016\/j.hoc.2011.02.002_bib20","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1001\/jama.265.24.3270","article-title":"Epidemiology of Rh hemolytic disease of the newborn in the United States","volume":"265","author":"Chavez","year":"1991","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5858\/2000-124-1118-PAPRTW","article-title":"Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists","volume":"124","author":"Domen","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"10.1016\/j.hoc.2011.02.002_bib22","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma","volume":"339","author":"Lo","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hoc.2011.02.002_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1056\/NEJM199308263290903","article-title":"Prenatal determination of fetal RhD type by DNA amplification","volume":"329","author":"Bennett","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2011.02.002_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.35.5.815","article-title":"Amniotic fluid spectrophotometry and early delivery in the management of erythroblastosis fetalis","volume":"35","author":"Bowman","year":"1965","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e3181da7929","article-title":"Fetomaternal hemorrhage","volume":"115","author":"Wylie","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.hoc.2011.02.002_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(16)36265-2","article-title":"Liquor amnil analysis in the management of the pregnancy complicated by rhesus sensitization","volume":"82","author":"Liley","year":"1961","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-9378(91)90281-U","article-title":"Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia","volume":"165","author":"Weiner","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for Doppler assessment of the blood velocity in anemic fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"3712","key":"10.1016\/j.hoc.2011.02.002_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.151.3712.828","article-title":"Rh factor: prevention of isoimmunization and clinical trial on mothers","volume":"151","author":"Freda","year":"1966","journal-title":"Science"},{"issue":"6578","key":"10.1016\/j.hoc.2011.02.002_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bmj.294.6578.1001","article-title":"Deaths from Rh haemolytic disease in England and Wales in 1984 and 1985","volume":"294","author":"Clarke","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib31","first-page":"349","article-title":"Effect on primary Rh immunization of delayed administration of anti-Rh","volume":"28","author":"Samson","year":"1975","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1423-0410.1999.7630175.x","article-title":"A\u00a0second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland","volume":"76","author":"Smith","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.hoc.2011.02.002_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn","author":"Brinc","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.2007.00945.x","article-title":"Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers","volume":"93","author":"Kumpel","year":"2007","journal-title":"Vox Sang"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM200102223440807","article-title":"Neonatal hyperbilirubinemia","volume":"344","author":"Dennery","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2 Pt 2","key":"10.1016\/j.hoc.2011.02.002_bib36","first-page":"417","article-title":"Morbidity and mortality associated with exchange transfusion","volume":"75","author":"Keenan","year":"1985","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tmrv.2008.09.006","article-title":"Transfusion-associated graft-versus-host disease","volume":"23","author":"Ruhl","year":"2009","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0029-7844(96)00113-5","article-title":"Fetal transfusion for red blood cell alloimmunization in pregnancy","volume":"88","author":"Schumacher","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"5365","key":"10.1016\/j.hoc.2011.02.002_bib39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bmj.2.5365.1107","article-title":"Intrauterine transfusion of foetus in haemolytic disease","volume":"2","author":"Liley","year":"1963","journal-title":"Br Med J"},{"issue":"8221","key":"10.1016\/j.hoc.2011.02.002_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(81)91549-X","article-title":"Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation","volume":"1","author":"Rodeck","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0002-9378(90)91314-3","article-title":"Intrauterine transfusion\u2014intraperitoneal versus intravascular approach: a case-control comparison","volume":"162","author":"Harman","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajog.2006.10.895","article-title":"High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus","volume":"196","author":"Schonewille","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0002-9378(97)70263-1","article-title":"The effect of the source of transfused blood on the rate of consumption of transfused red blood cells in pregnancies affected by red blood cell alloimmunization","volume":"177","author":"el-Azeem","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.hoc.2011.02.002_bib44","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198605293142207","article-title":"In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis","volume":"314","author":"Grannum","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib45","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmrv.2006.08.003","article-title":"Blood group antibodies and their significance in transfusion medicine","volume":"21","author":"Poole","year":"2007","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9378(86)90398-4","article-title":"Kell sensitization in pregnancy","volume":"154","author":"Caine","year":"1986","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9378(96)70425-8","article-title":"Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia","volume":"174","author":"Weiner","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3476(79)80533-8","article-title":"The spectrum of ABO hemolytic disease of the newborn infant","volume":"95","author":"Desjardins","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.hoc.2011.02.002_bib51","first-page":"700","article-title":"Thrombocytopenic purpura in pregnancy and in the newborn","volume":"130","author":"Patterson","year":"1946","journal-title":"J\u00a0Am Med Assoc"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib52","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.V84.6.1851.1851","article-title":"Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings","volume":"84","author":"Hohlfeld","year":"1994","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.002_bib53","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1182\/blood.V89.12.4402","article-title":"Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group","volume":"89","author":"Dreyfus","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2011.02.002_bib54","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.002_bib55","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib56","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A\u00a0screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V68.2.488.488","article-title":"Determination of platelet antigens and glycoproteins in the human fetus","volume":"68","author":"Gruel","year":"1986","journal-title":"Blood"},{"issue":"8710","key":"10.1016\/j.hoc.2011.02.002_bib58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0140-6736(90)91842-X","article-title":"Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia","volume":"336","author":"Giovangrandi","year":"1990","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib59","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1182\/blood.V81.8.2174.2174","article-title":"Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions","volume":"81","author":"Murphy","year":"1993","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199707033370104","article-title":"Fetal alloimmune thrombocytopenia","volume":"337","author":"Bussel","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.hoc.2011.02.002_bib61","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"issue":"8634","key":"10.1016\/j.hoc.2011.02.002_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.blre.2007.09.002","article-title":"Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates","volume":"22","author":"Bussel","year":"2008","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1423-0410.2003.00331.x","article-title":"Nomenclature of human platelet antigens","volume":"85","author":"Metcalfe","year":"2003","journal-title":"Vox Sang"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib66","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood-2008-06-077891","article-title":"The GPIIb\/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend","volume":"112","author":"Coller","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jmb.2007.05.025","article-title":"Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity","volume":"371","author":"Parry","year":"2007","journal-title":"J\u00a0Mol Biol"},{"issue":"9","key":"10.1016\/j.hoc.2011.02.002_bib68","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1537-2995.2005.00561.x","article-title":"Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia","volume":"45","author":"Peterson","year":"2005","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib69","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/OGX.0b013e31816412d3","article-title":"Fetal\/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future","volume":"63","author":"Serrarens-Janssen","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1423-0410.1980.tb01845.x","article-title":"Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia","volume":"39","author":"von dem Borne","year":"1980","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib72","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood.V65.6.1412.bloodjournal6561412","article-title":"Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a \u201cnew\u201d maternal antiplatelet antibody","volume":"65","author":"Friedman","year":"1985","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib73","first-page":"109","article-title":"A\u00a0second case of neonatal alloimmune thrombocytopenia associated with anti-PlA2 (Zwb) antibodies","volume":"22","author":"Maslanka","year":"1989","journal-title":"Haematologia (Budap)"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.1994.tb08315.x","article-title":"A\u00a0case of severe neonatal thrombocytopenia with schizencephaly associated with anti-HPA-1b and anti-HPA-2a","volume":"87","author":"Kuijpers","year":"1994","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1423-0410.1994.tb05037.x","article-title":"Neonatal thrombocytopenia in HLA-DR, -DQ, -DP-typed mother due to rare anti-HPA-1b (PLA2) (Zwb) fetomaternal immunization","volume":"67","author":"Mercier","year":"1994","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1995.tb03325.x","article-title":"Anti-HPA-1b really causes neonatal thrombocytopenia","volume":"89","author":"Van den Anker","year":"1995","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1423-0410.1998.7440256.x","article-title":"Neonatal alloimmune thrombocytopenia due to anti-HPA-1b (PLA2) (Zwb). A case report and review","volume":"74","author":"Winters","year":"1998","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib78","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1067\/mpd.2001.114029","article-title":"Anti-HPA-3A induces severe neonatal alloimmune thrombocytopenia","volume":"138","author":"Glade-Bender","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib79","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1537-2995.2009.02557.x","article-title":"Neonatal alloimmune thrombocytopenia caused by an antibody specific for a newly identified allele of human platelet antigen-7","volume":"50","author":"Koh","year":"2010","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib80","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1537-2995.2009.02537.x","article-title":"The first case of alloantibody against human platelet antigen-15b in Japan: possible alloimmunization by a hydatidiform mole","volume":"50","author":"Matsuhashi","year":"2010","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib81","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1991.tb04459.x","article-title":"HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases","volume":"78","author":"Kaplan","year":"1991","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2141.2000.02146.x","article-title":"Anti-HPA-5b-induced neonatal alloimmune thrombocytopenia: antibody titre as a predictor. Collaborative Study Group","volume":"110","author":"Ohto","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib83","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.1995.tb05597.x","article-title":"Maternal alloimmunization against fetal platelet antigens: a prospective study","volume":"90","author":"Panzer","year":"1995","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1423-0410.1986.tb04874.x","article-title":"Yuka, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia","volume":"50","author":"Shibata","year":"1986","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/tm.2000.7397","article-title":"HLA antibodies and fetomaternal alloimmune thrombocytopenia: myth or meaningful?","volume":"14","author":"Taaning","year":"2000","journal-title":"Transfus Med Rev"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib86","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.blre.2008.03.004","article-title":"Thrombocytopenia in the neonate","volume":"22","author":"Roberts","year":"2008","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOH.0b013e3283317be9","article-title":"Is it time to implement HPA-1 screening in pregnancy?","volume":"16","author":"Husebekk","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib89","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids\u2014more questions than answers. European Working Group on FMAIT","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.hoc.2011.02.002_bib92","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.AOG.0000270302.80336.dd","article-title":"Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial","volume":"110","author":"Berkowitz","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.hoc.2011.02.002_bib93","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"8403","key":"10.1016\/j.hoc.2011.02.002_bib94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(84)90614-7","article-title":"Prenatal treatment of alloimmune thrombocytopenia","volume":"2","author":"Daffos","year":"1984","journal-title":"Lancet"},{"issue":"9516","key":"10.1016\/j.hoc.2011.02.002_bib95","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib96","first-page":"875","article-title":"Prevention and management of postpartum hemorrhage","volume":"75","author":"Anderson","year":"2007","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0301-2115(03)00639-0","article-title":"Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or\u00a0= 500 ml) and severe (> or\u00a0= 1000 ml) postpartum haemorrhage","volume":"115","author":"Bais","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib98","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/AOG.0b013e3181a66b05","article-title":"Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population","volume":"113","author":"Sosa","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.hoc.2011.02.002_bib99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0306-5456(01)00230-3","article-title":"Secondary postpartum haemorrhage: incidence, morbidity and current management","volume":"108","author":"Hoveyda","year":"2001","journal-title":"BJOG"},{"issue":"5\/6","key":"10.1016\/j.hoc.2011.02.002_bib100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0049-3848(96)00057-6","article-title":"Thrombin-inhibitor complexes in the blood during and after delivery","volume":"82","author":"Andersson","year":"1996","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2004.01108.x","article-title":"D-dimer levels during delivery and the postpartum","volume":"3","author":"Epiney","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib103","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2141.2003.04790.x","article-title":"Current understanding of disseminated intravascular coagulation","volume":"124","author":"Levi","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajh.10450","article-title":"Morphologic diagnosis of thrombotic thrombocytopenic purpura","volume":"75","author":"Burns","year":"2004","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib106","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib107","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.hoc.2011.02.002_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007872.pub2","article-title":"Tranexamic acid for preventing postpartum haemorrhage","volume":"7","author":"Novikova","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib109","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2006.06355.x","article-title":"Guidelines on the management of massive blood loss","volume":"135","author":"British Committee for Standards in Haematology","year":"2006","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/AOG.0b013e3181a4b390","article-title":"Whole blood in the management of hypovolemia due to obstetric hemorrhage","volume":"113","author":"Alexander","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.hoc.2011.02.002_bib111","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/asheducation-2010.1.465","article-title":"Optimal use of blood products in severely injured trauma patients","volume":"2010","author":"Holcomb","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib112","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/SLA.0b013e31818990ed","article-title":"Early aggressive use of fresh frozen plasma does not improve\u00a0outcome in critically injured trauma patients","volume":"248","author":"Scalea","year":"2008","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.002_bib113","first-page":"358","article-title":"The relationship of blood product ratio to mortality: survival benefit or survival bias?","volume":"66","author":"Snyder","year":"2009","journal-title":"J\u00a0Trauma"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib114","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1537-2995.2009.02458.x","article-title":"Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets\u2014a review of the current literature","volume":"50","author":"Johansson","year":"2010","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib115","first-page":"886","article-title":"The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients","volume":"55","author":"Meng","year":"2003","journal-title":"J\u00a0Trauma"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib116","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1538-7836.2003.00225.x","article-title":"Mechanism of action of recombinant factor VIIa","volume":"1","author":"Lisman","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9353","key":"10.1016\/j.hoc.2011.02.002_bib117","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib118","first-page":"8","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"J\u00a0Trauma"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib119","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.20470","article-title":"Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation","volume":"11","author":"Lodge","year":"2005","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.hoc.2011.02.002_bib120","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/j.1538-7836.2005.01523.x","article-title":"Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation","volume":"3","author":"Pihusch","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib121","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.hoc.2011.02.002_bib122","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/BRS.0b013e3181557d45","article-title":"Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"32","author":"Sachs","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"issue":"20","key":"10.1016\/j.hoc.2011.02.002_bib123","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery","volume":"120","author":"Gill","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","volume":"114","author":"Moscard\u00f3","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib126","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0029-7844(03)00350-8","article-title":"Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII","volume":"101","author":"Bouwmeester","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib127","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.2004.00058.x","article-title":"Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature","volume":"111","author":"Boehlen","year":"2004","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.hoc.2011.02.002_bib128","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.0001-6349.2004.00501.x","article-title":"The use of recombinant factor VIIa in severe postpartum hemorrhage","volume":"83","author":"Segal","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.002_bib129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aei094","article-title":"Recombinant factor VIIa for life-threatening post-partum haemorrhage","volume":"94","author":"Ahonen","year":"2005","journal-title":"Br J Anaesth"},{"issue":"3 Pt 2","key":"10.1016\/j.hoc.2011.02.002_bib130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.AOG.0000197064.44340.d4","article-title":"Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation","volume":"108","author":"Pepas","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.002_bib131","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/00016340600855839","article-title":"Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use","volume":"85","author":"Sobieszczyk","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib132","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.AOG.0000288515.48066.99","article-title":"Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000\u20132004","volume":"110","author":"Alfirevic","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijoa.2006.07.005","article-title":"Use of recombinant activated factor VII in massive obstetric haemorrhage","volume":"16","author":"Haynes","year":"2007","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib134","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1066022","article-title":"A\u00a0critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage","volume":"34","author":"Franchini","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.002_bib135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-5994.2007.01472.x","article-title":"Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register","volume":"38","author":"Isbister","year":"2008","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.002_bib136","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1537-2995.2008.02029.x","article-title":"Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage","volume":"49","author":"Lewis","year":"2009","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2011.02.002_bib137","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MBC.0b013e32822d2a3c","article-title":"Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review","volume":"18","author":"Franchini","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib138","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","article-title":"The use of recombinant activated FVII in postpartum hemorrhage","volume":"53","author":"Franchini","year":"2010","journal-title":"Clin Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.hoc.2011.02.002_bib139","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.002_bib140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.AOG.0000249611.67873.94","article-title":"Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection","volume":"109","author":"Nagel","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.002_bib141","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.siny.2007.06.007","article-title":"Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia","volume":"12","author":"Oepkes","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.002_bib142","first-page":"1195","article-title":"Exposure to fifth disease in pregnancy","volume":"55","author":"Staroselsky","year":"2009","journal-title":"Can Fam Physician"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858811000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858811000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T23:01:11Z","timestamp":1686006071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858811000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0889858811000128"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2011.02.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}